Premium
Use of MLL/GRAF fusion mRNA for measurement of minimal residual disease during chemotherapy in an infant with acute monoblastic leukemia (AML‐M5)
Author(s) -
Wilda Monika,
Perez Antje Vega,
Bruch Jochen,
Woessmann Wilhelm,
Metzler Markus,
Fuchs Uta,
Borkhardt Arndt
Publication year - 2005
Publication title -
genes, chromosomes and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.754
H-Index - 119
eISSN - 1098-2264
pISSN - 1045-2257
DOI - 10.1002/gcc.20182
Subject(s) - hematology , medicine , oncology , pediatric oncology , minimal residual disease , leukemia , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom